Experimental mRNA Vaccine Hints at Potential Against Glioblastoma - Cancer Currents Blog

National Cancer Institute sent this bulletin at 06/12/2024 08:21 AM EDT

Having trouble viewing this email? View it as a Web page.

Experimental mRNA Vaccine Hints at Potential Against Glioblastoma
06/11/2024
	Recent results from several small clinical trials have suggested it may be possible to develop an effective immunotherapy for glioblastoma. Among them are findings from a four-patient trial testing a unique type of mRNA cancer vaccine.

You are subscribed to the latest posts from Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Update your subscriptions.